Neutrophilic inflammation in severe asthma

International Archives of Allergy and Immunology

Volumn 158, Issue SUPPL. 1, 2012, Pages 96-102

  Nakagome, Kazuyuki ^a   Matsushita, Sho ^a   Nagata, Makoto ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Airway inflammation; Eosinophils; Interleukin 8, interleukin 17; Neutrophils; Severe asthma

Indexed keywords

CORTICOSTEROID; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; PRAMIPEXOLE;

ASTHMA; CELL DIFFERENTIATION; CELL MIGRATION; CELL STIMULATION; CONFERENCE PAPER; DRUG MECHANISM; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NEUTROPHIL; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY TRACT DISEASE; TH17 CELL;

ANIMALS; ASTHMA; CELL MOVEMENT; HUMANS; INTERLEUKIN-8; NEUTROPHILS; PNEUMONIA; RECEPTORS, DOPAMINE D1; TH17 CELLS;

EID: 84861589003     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000337801     Document Type: Conference Paper

References (49)

1. Bochner BS, Undem BJ, Lichtenstein LM: Immunological aspects of allergic asthma. Annu Rev Immunol 1994; 12:295-335. (Pubitemid 24140417)
2. Gleich GJ: Mechanisms of eosinophil-asso-ciated inflammation. J Allergy Clin Immunol 2000; 105:651-663.
3. Weller PF: Human eosinophils. J Allergy Clin Immunol 2000; 100:283-287.
4. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2144-2148.
5. Kips JC, O'Connor BJ, Langley SJ, Woodcock A, Kerstjens HA, Postma DS, Danzig M, Cuss F, Pauwels RA: Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Ca re Med 2003; 16 7: 16 5 5-16 5 9.
6. Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L, Robinson D, Wenzel S, Busse W, Hansel TT, Barnes NC, International Mepolizumab Study Group: A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med 2007; 176:1062-1071. (Pubitemid 350223751)
7. Wenzel SE, Schwartz LB, Langmack EL, Hal-liday JL, Trudeau JB, Gibbs RL, Chu HW: Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160: 1001-1008. (Pubitemid 29442043)
8. The ENFUMOSA Study Group: The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003; 22: 470-477.
9. Kikuchi S, Kikuchi I, Hagiwara K, Kanazawa M, Nagata M: Association of tumor necrosis factor-a and neutrophilic inflammation in severe asthma. Allergol Int 2005; 54: 621-625. (Pubitemid 46206914)
10. Kikuchi S, Nagata M, Kikuchi I, Hagiwara K, Kanazawa M: Association between neutrophilic and eosinophilic inflammation in patients with severe persistent asthma. Int Arch Allergy Immunol 2005; 137(S1):7-11. (Pubitemid 40868767)
11. Pepe C, Foley S, Shannon J, Lemiere C, Oli-venstein R, Ernst P, Ludwig MS, Martin JG, Hamid Q: Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 2005; 116: 544-549. (Pubitemid 41267126)
12. Shannon J, Ernst P, Yamauchi Y, Olivenstein R, Lemiere C, Foley S, Cicora L, Ludwig M, Hamid Q, Martin JG: Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 2008; 133: 420-426. (Pubitemid 351272400)
13. Kikuchi S, Kikuchi I, Takaku Y, Kobayashi T, Hagiwara K, Kanazawa M, Nagata M: Neutrophilic inflammation and CXC chemo-kines in patients with refractory asthma. Int Arch Allergy Immunol 2009; 149(S1):87-93.
14. Kikuchi I, Kikuchi S, Kobayashi T, Hagiwara K, Sakamoto Y, Kanazawa M, Nagata M: Eosinophil trans-basement membrane migration induced by interleukin-8 and neutrophils. Am J Respir Cell Mol Biol 2006; 34: 760-765. (Pubitemid 43825342)
15. Kobayashi T, Takaku Y, Kikuchi I, Soma T, Hagiwara K, Kanazawa M, Nagata M: Eosinophils do not enhance the trans-basement-membrane migration of neutrophils. Int Arch Allergy Immunol 2007; 143(s1):38-43. (Pubitemid 46854790)
16. Kikuchi I, Kikuchi S, Kobayashi T, Takaku Y, Hagiwara K, Kanazawa M, Nagata M: Theophylline attenuates the neutrophil-depen-dent augmentation of eosinophil trans-basement membrane migration. Int Arch Allergy Immunol 2007; 143: 44-49. (Pubitemid 46854791)
17. 2 integrin. Immunology 2000; 101:412-418.
18. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G: Neutrophil gelati-nase B potentiates interleukin-8 ten-fold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-a and leaves RANTES and MCP-2 intact. Blood 2000; 96:2673-2681.
19. Goleva E, Hauk PJ, Hall CF, Liu AH, Riches DW, Martin RJ, Leung DY: Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J Allergy Clin Immunol 2008; 122: 550-559.
20. Zhu Z, Zheng T, Homer RJ, Kim YK, Chen NY, Cohn L, Hamid Q, Elias JA: Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004; 304: 1678-1682. (Pubitemid 38765861)
21. Hong JH, Hong JY, Park B, Lee SI, Seo JT, Kim KE, Sohn MH, Shin DM: Chitinase activates protease-activated receptor-2 in human airway epithelial cells. Am J Respir Cell Mol Biol 2008; 39: 530-535.
22. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA: Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986: 137:1893-1896. (Pubitemid 16021101)
23. Smart SJ, Casale TB: TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent. Am J Physiol 1994; 266: 238-245.
24. Hiraguchi Y, Nagao M, Hosoki K, Tokuda R Fujisawa T: Neutrophil Proteases Activate Eosinophil Function in vitro. Int Arch Allergy Immunol 2008; 146(s1):16-21.
25. Liu H, Lazarus SC, Caughey GH, Fahy JV: Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro. Am J Physiol 1999; 276:L28-L34. (Pubitemid 29061661)
26. Randolph DA, Stephens R, Carruthers CJ, Chaplin DD: Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest 1999; 104: 1021-1029. (Pubitemid 29536312)
27. Randolph DA, Carruthers CJ, Szabo SJ, Murphy KM, Chaplin DD: Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 1999; 162: 2375-2383. (Pubitemid 29288865)
28. H 17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 2008; 81: 4089-4097.
29. Barczyk A, Pierzchala W, Sozanska E: In-terleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 2003; 97:726-733. (Pubitemid 36675678)
30. H 17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 2009; 123:1185-1187.
31. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998; 392: 245-252. (Pubitemid 28155090)
32. Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, Afkarian M, Murphy TL: Signaling and transcription in T helper development. Annu Rev Immunol 2000; 18: 451-460.
33. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA: Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000; 106:551-559. (Pubitemid 30666388)
34. Matsushita S, Takagi R, Hashimoto K, Hi-gashi T: Qualitative evaluation of adjuvant activities and its application to Th2/17 diseases. Int Arch Allergy Immunol 2011; 155(s1):2-5.
35. Nakano K, Higashi T, Hashimoto K, Takagi R, Tanaka Y, Matsushita S: Antagonizing do-pamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem Biophys Res Com-mun 2008; 373: 286-291.
36. Nakano K, Higashi T, Takagi R, Hashimoto K, Tanaka Y, Matsushita S: Dopamine released by dendritic cells polarizes Th2 differentiation. Int Immunol 2009; 21: 645-654.
37. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG: Dopamine receptors: from structure to function. Physiol Rev 1998; 78: 189-225. (Pubitemid 28070979)
38. Hashimoto K, Inoue T, Higashi T, Takei S, Awata T, Katayama S, Takagi R, Okada H, Matsushita S: Dopamine D1-like receptor antagonist, SCH23390, exhibits a preventive effect on diabetes mellitus that occurs naturally in NOD mice. Biochem Biophys Res Commun 2009; 383:460-463.
39. Okada H, Inoue T, Hashimoto K, Suzuki H, Matsushita S: D1-like receptor antagonist inhibits IL-17 expression and attenuates crescent formation in nephrotoxic serum nephritis. Am J Nephrol 2009; 30:274-279.
40. + T cells in afi-T cell receptor transgenic mice. Am J Respir Crit Care Med 2000; 161: 1340-1348. (Pubitemid 30243850)
41. Wilder JA, Collie DD, Bice DE, Tesfaigzi Y, Lyons CR, Lipscomb MF: Ovalbumin aerosols induce airway hyperreactivity in naïve DO11.10 T cell receptor transgenic mice without pulmonary eosinophilia or OVA-specific antibody. J Leukoc Biol 2001; 69: 538-547. (Pubitemid 32294838)
42. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y: Antigen-specific T cell sensitiza-tion is impaired in IL-17-deficient mice, causing suppression of allergic cellular and hu moral responses. Immunity 2002; 17: 375-387. (Pubitemid 35279557)
43. Nakae S, Suto H, Berry GJ, Galli SJ: Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood 2007; 109: 3640-3648. (Pubitemid 46641710)
44. Nakagome K, Imamura M, Okada H, Kawahata K, Inoue T, Hashimoto K, Harada H, Higashi T, Takagi R, Nakano K, Hagiwara K, Kanazawa M, Dohi M, Nagata M, Matsushita S: Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophil-ic airway inflammation. J Immunol 2011; 18 6: 5975-5982.
45. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL: Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003; 278: 1910-1914. (Pubitemid 36801431)
46. Antonini A, Barone P: Dopamine agonist-based strategies in the treatment of Parkinson's disease. Neurol Sci 2008; 29(s5): S371-S374.
47. Howarth PH, Babu KS, Arshad HS, Lau L, Buckley M, McConnell W, Beckett P, Al Ali M, Chauhan A, Wilson SJ, Reynolds A, Davies DE, Holgate ST: Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005; 60:1012-1018. (Pubitemid 41705469)
48. Wenzel SE, Barnes PJ, Bleecker ER, Bousquet J, Busse W, Dahlén SE, Holgate ST, Meyers DA, Rabe KF, Antczak A, Baker J, Horvath I, Mark Z, Bernstein D, Kerwin E, Schlenker-Herceg R, Lo KH, Watt R, Barnathan ES, Chanez P, T03 Asthma Investigators: A randomized, double-blind, placebo-controlled study of tumor necrosis factor-a blockade in severe persistent asthma. Am J Respir Crit Care Med 2009; 179: 549-558.
49. Kraft M, Torvik JA, Trudeau JB, Wenzel SE, Martin RJ: Theophylline: potential anti-inflammatory effects in nocturnal asthma. J Allergy Clin Immunol 1996; 97:1242-1246. (Pubitemid 26192273)